MESSA, PIERGIORGIO
 Distribuzione geografica
Continente #
NA - Nord America 22.817
AS - Asia 18.895
EU - Europa 17.807
Continente sconosciuto - Info sul continente non disponibili 2.584
SA - Sud America 1.846
AF - Africa 440
OC - Oceania 168
Totale 64.557
Nazione #
US - Stati Uniti d'America 21.750
CN - Cina 6.127
SG - Singapore 5.504
IT - Italia 4.853
GB - Regno Unito 4.520
SE - Svezia 1.561
RU - Federazione Russa 1.509
HK - Hong Kong 1.372
DE - Germania 1.356
BR - Brasile 1.306
VN - Vietnam 1.272
BD - Bangladesh 1.204
FR - Francia 968
IN - India 764
IE - Irlanda 583
NL - Olanda 575
CA - Canada 571
JP - Giappone 568
ID - Indonesia 475
FI - Finlandia 413
MX - Messico 303
TR - Turchia 282
KR - Corea 251
ES - Italia 250
UA - Ucraina 191
TW - Taiwan 182
DK - Danimarca 180
AU - Australia 143
AR - Argentina 138
CO - Colombia 131
BE - Belgio 124
CI - Costa d'Avorio 104
CH - Svizzera 102
PL - Polonia 101
TH - Thailandia 95
PK - Pakistan 94
IR - Iran 88
AT - Austria 87
IQ - Iraq 85
EG - Egitto 80
GR - Grecia 78
PH - Filippine 75
MY - Malesia 69
SA - Arabia Saudita 67
ZA - Sudafrica 66
PE - Perù 64
CL - Cile 62
EU - Europa 62
PT - Portogallo 58
RO - Romania 55
MA - Marocco 52
VE - Venezuela 50
IL - Israele 43
NP - Nepal 42
EC - Ecuador 41
UZ - Uzbekistan 36
CR - Costa Rica 32
RS - Serbia 32
GT - Guatemala 31
JM - Giamaica 29
KE - Kenya 29
HR - Croazia 26
JO - Giordania 25
TN - Tunisia 25
HU - Ungheria 22
LT - Lituania 22
HN - Honduras 21
NO - Norvegia 21
NZ - Nuova Zelanda 21
BO - Bolivia 20
AE - Emirati Arabi Uniti 19
CZ - Repubblica Ceca 19
KZ - Kazakistan 19
PY - Paraguay 17
BG - Bulgaria 16
DZ - Algeria 16
LU - Lussemburgo 16
CY - Cipro 15
NG - Nigeria 15
OM - Oman 15
UY - Uruguay 14
SN - Senegal 13
LB - Libano 12
LK - Sri Lanka 12
TT - Trinidad e Tobago 12
AZ - Azerbaigian 11
SV - El Salvador 11
SI - Slovenia 10
AL - Albania 9
DO - Repubblica Dominicana 9
SD - Sudan 9
ET - Etiopia 8
KW - Kuwait 8
MK - Macedonia 8
PA - Panama 8
SY - Repubblica araba siriana 8
BY - Bielorussia 7
KH - Cambogia 7
LV - Lettonia 7
PR - Porto Rico 7
Totale 61.895
Città #
Southend 3.859
Singapore 3.107
Ashburn 2.066
Chandler 1.271
Fairfield 1.205
San Jose 1.203
Hong Kong 1.199
Houston 1.025
Milan 1.021
Beijing 977
Council Bluffs 825
Princeton 696
Dallas 677
Santa Clara 639
Seattle 630
Wilmington 577
Woodbridge 570
Dublin 561
Los Angeles 538
Redwood City 503
Ann Arbor 477
Nanjing 444
New York 415
Cambridge 402
Guangzhou 361
Rome 332
Lauterbourg 331
Hanoi 322
Ho Chi Minh City 311
Jakarta 299
Shenzhen 298
Dearborn 293
Helsinki 292
Buffalo 290
Boardman 289
Des Moines 273
Hanover 267
Frankfurt am Main 265
Bengaluru 264
Columbus 214
Hangzhou 211
Tokyo 210
Shanghai 208
The Dalles 191
Moscow 175
Toronto 172
Phoenix 166
Jinan 163
Hefei 153
Munich 146
Shenyang 142
São Paulo 133
Tianjin 130
Chicago 120
Changsha 116
Naples 114
Cangzhou 113
Nanchang 113
San Diego 108
Zhengzhou 108
Abidjan 104
Hebei 102
Jacksonville 101
Bologna 97
Taipei 95
London 92
Istanbul 91
Seoul 90
Washington 87
Brussels 80
Atlanta 78
Turin 78
Dong Ket 74
Nuremberg 70
Mountain View 65
Mumbai 65
Silver Spring 65
Montreal 64
Florence 63
Bogotá 60
Redmond 60
Jiaxing 59
Bari 58
Berlin 56
Bangkok 54
Fuzhou 54
Ottawa 54
Central District 53
Da Nang 53
Kunming 53
Madrid 51
Catania 49
Wuhan 49
Brooklyn 46
Rio de Janeiro 46
Warsaw 46
San Francisco 45
Chengdu 44
Philadelphia 43
Palermo 42
Totale 35.216
Nome #
Dietary treatment of urinary risk factors for renal stone formation : A review of CLU Working Group 1.391
HCV, HBV, HIV ed emodialisi 1.382
Assessment of increased glomerular permeability associated with recurrent focal segmental glomerulosclerosis using an in vitro model of the glomerular filtration barrier 901
Rituximab as maintenance treatment for systemic Lupus Erythematosus: a multicentre observational study of 147 patients 816
Bone effects and safety of one year denosumab therapy in a cohort of renal transplanted patients: An observational monocentric study 780
Rituximab vs mycophenolate and vs cyclophosphamide pulses for induction therapy of active lupus nephritis: A clinical observational study 769
Iperfosfatemia in dialisi: la scelta del chelante 688
The long-term outcome of renal transplantation of IgA nephropathy and the impact of recurrence on graft survival 664
Summary of the International Conference on Onco-Nephrology: an emerging field in medicine 642
IgM Autoantibodies to Complement Factor H in Atypical Hemolytic Uremic Syndrome 524
Hepcidin levels in chronic hemodialysis patients : A critical evaluation 515
La doppia borsa di tabacco intorno alla cuffia profonda del catetere peritoneale: una tecnica per l’inizio immediato della CAPD [Double purse-string craft around the inner cuff: a new technique for an immediate start of CAPD] 504
Podocytes: Recent biomolecular developments 496
Erythropoietin Use and Immunogenicity of Hepatitis B Virus Vaccine in Chronic Kidney Disease Patients: A Meta-Analysis 406
I nuovi farmaci antivirali per la terapia di HCV post- trapianto renale 385
Metabolic acidosis in renal transplantation: Neglected but of potential clinical relevance 380
Farmaci ad azione antivirale diretta, epatite C e dialisi: un aggiornamento 379
HBV vaccination with Fendrix is effective and safe in pre-dialysis CKD population 368
The long-term outcome of 93 patients with proliferative lupus nephritis 360
VDRA therapy is associated with improved survival in dialysis patients with serum intact PTH ≤ 150 pg/mL: results of the Italian FARO Survey 355
FGF23 and Fetuin-A Interaction and Mesenchymal Osteogenic Transformation 341
NeuroD Expression in Podocytes and Interrelationships with Nephrin at Both Nuclear and Cytoplasmic Sites 327
Membranous Nephropathy (MN) Recurrence after Renal Transplantation 303
Nuovi scenari nell’iperparatiroidismo secondario: etelcalcetide : Position Paper dei Nefrologi lombardi [New scenarios in secondary hyperparathyroidism: etelcalcetide. Position paper of Nephrologists form Lombardy] 285
End-stage renal disease costs for patients new to hemodialysis in Italy: The FARO-2 Study 282
A new approach for anemia in kidney disease 282
The A736V TMPRSS6 polymorphism influences hepcidin and iron metabolism in chronic hemodialysis patients : TMPRSS6 and hepcidin in hemodialysis 278
Haploidentical Hematopoietic Stem Cell Transplant Complicated by Atypical Hemolytic Uremic Syndrome and Kidney Transplant from the Same Donor with No Immunosuppression but C5 Inhibition 278
Effect of a home based, low intensity, physical exercise program in older adults dialysis patients: A secondary analysis of the EXCITE trial 278
Therapeutic Effect of Iron Citrate in Blocking Calcium Deposition in High Pi-Calcified VSMC: Role of Autophagy and Apoptosis 278
How a skilful and motivated urinary sediment examination can save the kidneys 276
A dvanced glycation end products (ages) and soluble receptor for AGES (SRAGE): Association with risk of mortality in chronic kidney disease patients 276
Long-term evaluation of coronary artery calcifications in kidney transplanted patients : a follow up of 5 years 270
FGF23-regulated production of Fetuin-A (AHSG) in osteocytes 269
Long-term outcome of renal transplantation in patients with idiopathic membranous glomerulonephritis (MN) 266
Urgent-start PD: un approccio perseguibile 262
Pratica clinica per la diagnostica delle aritmie cardiache in pazienti in terapia renale sostitutiva: dati di una survey lombarda 257
Vitamin K in Chronic Kidney Disease 255
Natural history of hepatitis B and C in renal allograft recipients 252
Fluorinated-PLGA Nanoparticles for Enhanced Drug Encapsulation and 19F-NMR Detection 252
High-phosphate induced vascular calcification is reduced by iron citrate through inhibition of extracellular matrix osteo-chondrogenic shift in VSMCs 247
ERRATUM: Dietary treatment of urinary risk factors for renal stone formation : A review of CLU Working Group 246
Kinetics of hepatitis B virus load during haemodialysis sessions and α-interferon: A prospective study 245
Physical performance and clinical outcomes in dialysis patients: A secondary analysis of the excite trial 242
Complement functional tests for monitoring eculizumab treatment in patients with atypical hemolytic uremic syndrome: an update 241
Pathophysiology of calcium and phosphate metabolism impairment in Chronic Kidney Disease 240
Persistent secondary hyperparathyroidism after renal transplantation 240
Immunoglobulin A Nephropathy. Recurrence After Renal Transplantation 240
Trattamento dell’iperuricemia nel paziente nefropatico: è giunto il momento di agire? 240
Glomerular autoimmune multicomponents of human lupus nephritis in vivo (2): Planted antigens 239
Peritoneal Dialysis for Potential Kidney Transplant Recipients: Pride or Prejudice? 237
Sarcopenia is Associated with Malnutrition but Not with Systemic Inflammation in Older Persons with Advanced CKD 235
Renal transplantation in adults with Henoch-Schonlein purpura: long-term outcome 234
Early involvement of cellular stress and inflammatory signals in the pathogenesis of tubulointerstitial kidney disease due to UMOD mutations 234
Effect of VDRA on survival in incident hemodialysis patients: results of the FARO-2 observational study 233
Luminex technology for anti-HLA antibody screening : evaluation of performance and of impact on laboratory routine 233
HFE gene mutations and oxidative stress influence serum ferritin, associated with vascular damage, in hemodialysis patients 231
Targeted silencing of GNAS in a human model of osteoprogenitor cells results in the deregulation of the osteogenic differentiation program 230
Hepatorenal syndrome and novel advances in its management 230
Gut microbiota composition and frailty in elderly patients with Chronic Kidney Disease 229
The OPTIMA study: assessing a new cinacalcet (Sensipar/Mimpara) treatment algorithm for secondary hyperparathyroidism 229
The value of a panel of autoantibodies for predicting the activity of lupus nephritis at time of renal biopsy 228
Everolimus with very low-exposure cyclosporine a in de novo kidney transplantation: a multicenter, randomized, controlled trial 228
Achievement of NKF/K-DOQI recommended target values for bone and mineral metabolism in incident hemodialysis patients : results of the FARO-2 Cohort 227
The role of immunosuppression in malignancies among 351 pediatric renal transplant patients 224
Lack of EULAR/ERA-EDTA response at 1 year predicts poor long-term renal outcome in patients with lupus nephritis 224
Complement functional tests for monitoring eculizumab treatment in patients with atypical hemolytic uremic syndrome 224
Calcium and osteoprotegerin levels predict the progression of the abdominal aortic calcifications after kidney transplantation 224
Nutritional vitamin D in renal transplant patients : speculations and reality 221
Podocyte developmental defects caused by adriamycin in zebrafish embryos and larvae: A novel model of glomerular damage 220
Deciphering Variability of PKD1 and PKD2 in an Italian Cohort of 643 Patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD) 220
Associations Between Cholesterol and Fatty Acid Profile on the Severity of Depression in Older Persons With Nondialysis Chronic Kidney Disease 220
Skin infection due to Alternaria species in kidney allograft recipients: report of a new case and review of literature 219
Fitness for entering a simple exercise program and mortality: A study corollary to the exercise introduction to enhance performance in dialysis (Excite) trial EXCITE working group 217
A randomized study evaluating cinacalcet to treat hypercalcemia in renal transplant recipients with persistent hyperparathyroidism 217
Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis 216
Graphene quantum dots : from efficient preparation to safe renal excretion 215
Vitamin B12 status in patients with renal failure 214
Alport syndrome and pregnancy: a case series and literature review 213
Real-world usage of Chronic Kidney Disease – Mineral Bone Disorder (CKD–MBD) biomarkers in nephrology practices 210
Discoidin domain receptor-1 and periostin: New players in chronic kidney disease 210
Carotid plaques in patients with long-term lupus nephritis 208
Evaluating targets and costs of treatment for secondary hyperparathyroidism in incident dialysis patients: the FARO-2 study 208
Inadequate diagnosis and therapy of arterial hypertension as causes of left ventricular hypertrophy in uremic dialysis patients 208
ANCA-associated vasculitis with renal involvement 207
Recombinant Hepatitis B Vaccine Adjuvanted With AS04 in Dialysis Patients: A Prospective Cohort Study 207
HFE mutations modulate the effect of iron on serum hepcidin-25 in chronic hemodialysis patients 207
Abnormal arachidonic acid content of red blood cell membranes and main lithogenic factors in stone formers 207
Iron citrate reduces high-phosphate induced vascular calcification by inhibiting osteo-chondrogenic shift of extracellular matrix in VSMCs 206
Il trapianto renale nel Nord Italia Transplant program (NITp) : assegnazione degli organi e risultati = Renal transplantation in the North Italy Transplant program (NITp) : organ allocation and results 205
The genetic architecture of membranous nephropathy and its potential to improve non-invasive diagnosis 205
Use of the Frailty Index in Older Persons with Chronic Kidney Disease 201
Direct-Acting Antiviral Agents for HCV-Associated Glomerular Disease and the Current Evidence 201
Advanced glycation end products (Age) and soluble forms of age receptor : Emerging role as mortality risk factors in CKD 201
Malignancies in 2753 kidney recipients transplanted during a 39-year experience 200
Pathophysiology of Non Alcoholic Fatty Liver Disease 200
Low-dose rituximab is poorly effective in patients with primary membranous nephropathy 200
Native Hypovitaminosis D in CKD Patients : From Experimental Evidence to Clinical Practice 197
Kidney transplant in patients with atypical hemolytic uremic syndrome in the anti-C5 era: single-center experience with tailored Eculizumab 197
ADPKD : clinical issues before and after renal transplantation 195
Totale 31.498
Categoria #
all - tutte 171.230
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 171.230


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20224.539 0 237 234 349 337 365 605 330 398 429 363 892
2022/20235.368 570 434 462 571 656 919 156 419 539 148 289 205
2023/20243.789 201 334 210 238 689 301 210 217 133 250 416 590
2024/20259.949 643 934 350 712 813 594 494 1.119 612 822 1.010 1.846
2025/202619.632 1.707 1.005 1.682 1.323 1.819 1.293 2.102 908 2.506 1.182 2.684 1.421
2026/20271.857 1.234 623 0 0 0 0 0 0 0 0 0 0
Totale 64.557